Atlas
Market PulseSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › BAYERCROP

BAYERCROP

Bayer Cropscience Limited
Small-capChemicals ↗

What the six lenses say about BAYERCROP — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹4120.2
2026-07-10
VWAP · 1Y anchor
₹4860
-15.2% from VWAP
P/E · TTM
649.9×
TTM EPS ₹6.3
52-week range
2%
position low→high
RSI(14)
40
momentum

Own sector index

Chemicals ↗
Neutral

1M

+0.9%

3M

+8.4%

1Y

—

Breadth >EMA21

44%

How BAYERCROP’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
3.0
avg conviction decile
Leadership
0/2
active lenses · Tech & Flow
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Small-cap cohortDRaw
TechnicalD23›

The actual numbers

Price vs VWAP (1y)-15.2%
EMA trend stackDown · 21<50<200
Price vs 200-EMA-11.2%
Price vs 50-EMA-4.6%
RSI(14)40
RS vs Nifty 500 · 3M-17.5%
RS vs sector · 3M-22.7%
52-week range2%
Volume vs 30d avg0.49×
Volume vs 60d avg0.69×
ATR(14) · volatility93.0
Bollinger width · vol contraction0.055
FundamentalD444›

The actual numbers

Return on equity (ROE)15.8%
Return on capital (ROCE)20.1%
Net margin7.0%
Debt / equity0.34×

Full 8-quarter history in the financials table below.

ValuationD850›

The actual numbers

P/E (TTM)649.9×
TTM EPS₹6.3
52-week range2%
Catalyst——›

Every filing in the corporate-announcements panel below.

FlowD442›

The actual numbers

Promoter holding68.7%
Delivery · 30d avg57.1%
Up/down-day asymmetry-7.1pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Small-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D2 + D4 ) ÷ 2 = 3.0(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Below threshold
6
Conviction score 6/100 · avg-decile strength 3.0/10
Conviction score6/100›
TechnicalD2›
FundamentalD4›
ValuationD8›
Catalyst
FlowD4›

Policy

Government policy · Chemicals

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Watch· MEDIUM impact

China+1 Manufacturing Shift

Supply-chain diversification away from China benefiting Indian chemical and component manufacturers

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-07-10.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
-1.4pp
+0.0pp
-7.4pp
-13.9pp
-1.1pp
-28.9pp
Nifty 500
Broad-market baseline
-1.8pp
-0.1pp
-8.0pp
-17.5pp
-6.2pp
-32.7pp
Sector
Own-sector index
—
—
-5.0pp
-22.7pp
-10.4pp
—

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

BAYERCROP daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
4120.20-43.30

Relative strength

RS vs baseline · rebased to 100

BAYERCROP ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
62.25-1.13

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

MetricDec '05Dec '06
Revenue (₹cr)223242
↳ change QoQ—+8.5%
EBITDA (₹cr)2918
EBITDA margin13.0%7.4%
PAT (₹cr)817
↳ change QoQ—+112.5%
Net margin3.6%7.0%
EPS (₹)1.974.37
D/E——
YoY growth · Dec '06Revenue n/aPAT n/a

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 9 Oct '13
    LOWgovernance
    News Verification
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗

Ownership

Who holds BAYERCROP

Mutual funds holding BAYERCROP (10)

FundWeightAUM ₹crGrade
Quant Small Cap Gr1.47%31,774
Aditya BSL Large Cap Gr Tr0.52%28,640
Aditya BSL Large Cap Gr0.52%28,640
DSP Small Cap Reg Gr0.95%18,358
Bandhan Flexi Cap Gr0.53%7,257
Bandhan ELSS Tax saver Reg Gr1.17%6,767
Bandhan Multi Cap Reg Gr1.00%2,919
DSP Multicap Reg Gr1.42%2,809
Tata India Pharma & Healthcare Reg Gr3.20%1,455
Bank of India Multi Cap Reg Gr1.17%1,110

ETFs holding BAYERCROP (1)

ETFWeightGrade
Kotak Nifty Chemicals ETF1.44%
Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Chemicals